Continued insulin aspart treatment after the intensive insulin therapy did not change TNF-α levels in T2DM patients, which might be related to obesity, lifestyle, and uncontrollable genetic factors. This evidence concerns the gene TNF and obesity due to melanocortin 4 receptor deficiency.